We are live on ! Find out more
PROK icon

ProKidney
PROK

67 hedge funds and large institutions have $187M invested in ProKidney in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less funds holding

Funds holding: 80 → 67 (-13)

16.54% less ownership

Funds ownership: 91.45% → 74.91% (-17%)

19% less capital invested

Capital invested by funds: $232M → $187M (-$45.1M)

57% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 23

59% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 17

Holders
67
Holders Change
-13
Holders Change %
-16.25%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
7
Reduced
17
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTCM
First Trust Capital Management
Illinois
+$7.42M
2
Marshall Wace
Marshall Wace
United Kingdom
+$5.42M
3
UOC
UBS O'Connor
Illinois
+$3.58M
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$3.03M
5
KPF
K2 Principal Fund
Ontario, Canada
+$1.35M

Top Sellers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
-$10.9M
2
Citadel Advisors
Citadel Advisors
Florida
-$5.1M
3
TCA
Taconic Capital Advisors
New York
-$4.94M
4
WAM
Weiss Asset Management
Massachusetts
-$4.46M
5
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$4.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
76
Polar Asset Management Partners
Ontario, Canada
– -$1.68M -170,000 Closed
WCM
77
Whitefort Capital Management
New York
– -$1.59M -160,615 Closed
CCM
78
Context Capital Management
California
– -$1.48M -149,400 Closed
BCM
79
BlueCrest Capital Management
Jersey
– -$1.24M -125,000 Closed
AAI
80
Aequim Alternative Investments
California
– -$988K -100,000 Closed
LCG
81
Luxor Capital Group
New York
– -$988K -100,000 Closed
SGM
82
Seven Grand Managers
New York
– -$990K -100,000 Closed
CCM
83
CAAS Capital Management
New York
– -$946K -95,602 Closed
CL
84
CSS LLC
Illinois
– -$830K -83,779 Closed
Citigroup
85
Citigroup
New York
– -$465K -47,100 Closed
RL
86
RPO LLC
Connecticut
– -$338K -34,138 Closed
Mirae Asset Global Investments
87
Mirae Asset Global Investments
South Korea
– -$210K -21,184 Closed
AA
88
Ancora Advisors
Ohio
– -$23K -2,333 Closed
TFS
89
TrustCore Financial Services
Tennessee
– -$10K -1,015 Closed
1 2 3
4

PROK Hedge Fund Activity: Q2 2022 in Review

67 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q2 2022, worth a combined $187M — down 19% from $232M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of PROK and 10 opened new positions — a net loss of 13 holders — while 17 trimmed existing stakes and 7 added.

The largest buyer was First Trust Capital Management, adding an estimated $7.42M. The largest seller was Kepos Capital, exiting entirely with an estimated $10.9M sold.

  • 67 institutional investors held ProKidney (PROK) as of Q2 2022, down from 80 in Q1 2022.
  • Funds reported $187M of ProKidney stock for Q2 2022, down 19% quarter-over-quarter.
  • 10 funds opened new ProKidney positions in Q2 2022 and 23 closed out, a net change of -13 holders.
  • The largest ProKidney buyer in Q2 2022 was First Trust Capital Management, an estimated $7.42M added.
  • The largest ProKidney seller in Q2 2022 was Kepos Capital, an estimated $10.9M sold.

Based on aggregated 13F filings for Q2 2022.